CJC-1295 DAC vs No DAC
The #1 Confusion in Peptide GH Stacks — Fully Resolved
CJC-1295 comes in two forms with fundamentally different pharmacokinetics. No DAC (Mod GRF 1-29) lasts 30 minutes and is injected daily. With DAC lasts 8 days via albumin binding and is injected weekly. Choosing the wrong form means using an entirely different protocol.
Head-to-Head Comparison
| Feature | No DAC (Mod GRF 1-29) | With DAC |
|---|---|---|
| Half-life | ~30 minutes | ~8 days (albumin-bound) |
| Injection Frequency | 1–3x daily | 1–2x weekly |
| GH Release Pattern | Pulsatile (physiologic) | Continuous GHRH signal |
| IGF-1 Effect | Moderate elevation (30–40%) | Higher sustained elevation (50%+) |
| Stacking with GHRP | Required for each injection | Optional; GHRP can be added separately |
| GH Pulsatility | Fully preserved | May blunt natural GH axis |
| Convenience | Lower (daily injections) | Higher (weekly injection) |
| Molecular Weight | ~3.3 kDa | ~3.6 kDa (DAC linker adds mass) |
| Blot Test Reaction | Not typical | Possible temporary redness/swelling |
What Is the Drug Affinity Complex?
The Drug Affinity Complex (DAC) is a chemical technology — specifically a maleimide-lysine linker — that is covalently attached to the CJC-1295 peptide. When injected, the maleimide group rapidly and covalently bonds to a free cysteine residue on serum albumin, the most abundant protein in human blood. Albumin has a circulating half-life of approximately 19 days, and this binding effectively extends CJC-1295's bioavailability to approximately 8 days.
The practical consequence is dramatic: instead of needing to inject GHRH signaling 1–3 times per day (as with No DAC), a single weekly injection of CJC-1295 DAC maintains near-continuous GHRH receptor stimulation. This is both the major advantage and the major trade-off of the DAC form. Continuous GHRH stimulation maintains elevated IGF-1 but may progressively reduce the amplitude of natural GH pulses — a concern for users who value physiologic GH pulsatility.
Blot test reaction: Some users experience temporary redness, warmth, or swelling at the CJC-1295 DAC injection site within 1–4 hours of administration. This reaction is attributed to the DAC moiety itself and is distinct from an allergic response to the peptide sequence. It is typically self-resolving within 12–24 hours. If you experience this, it does not indicate a problem with the peptide — it is a recognized pharmacological side effect of the albumin-binding mechanism.
Who Should Choose Each Form?
Choose No DAC (Mod GRF 1-29) If...
- →You want to preserve physiologic GH pulsatility and the natural GH axis
- →You are already injecting ipamorelin or another GHRP 2–3x daily and want CJC-1295 at each window
- →You prefer a more physiologic, conservative approach to GH peptide use
- →You want to avoid the blot test reaction associated with the DAC form
- →You are stacking for anti-aging, sleep quality, or general performance optimization
Choose With DAC If...
- →Convenience is a priority — 1–2 injections per week is highly appealing
- →Your primary goal is maximizing IGF-1 elevation rather than pulsatile GH amplitude
- →You are comfortable monitoring IGF-1 labs and adjusting dose to stay in range
- →You want a baseline GHRH signal and plan to add ipamorelin on top for daily GH pulses
- →You have experience with GH peptides and understand the trade-offs of continuous stimulation
FAQ
What does DAC stand for in CJC-1295 and what does it do?
DAC stands for Drug Affinity Complex — a maleimide-lysine chemical linker that covalently binds CJC-1295 to serum albumin after injection. Albumin has a circulating half-life of ~19 days, and albumin binding extends CJC-1295's effective half-life from ~30 minutes (No DAC) to approximately 8 days. This makes 1–2 weekly injections sufficient to maintain continuous GHRH receptor stimulation, replacing the 1–3 daily injections required by the No DAC form.
Which is better: CJC-1295 with DAC or without DAC?
Neither is universally superior — they target different goals. No DAC preserves physiologic pulsatile GH release and is required for traditional daily ipamorelin stacks. With DAC offers convenience and higher sustained IGF-1 levels but blunts natural GH pulsatility. Most users who prioritize anti-aging and performance prefer No DAC for pulsatility; users prioritizing maximum IGF-1 elevation with fewer injections prefer DAC.
Why do vendors often not specify DAC or No DAC?
This is the most common source of confusion in the research peptide market. Many vendors label products simply as "CJC-1295" without DAC clarification. The molecular weight differs: No DAC is ~3.3 kDa, With DAC is ~3.6 kDa. If a product is labeled "Mod GRF 1-29" it is always the No DAC form. When in doubt, treat as No DAC and do not inject weekly doses of what may be a daily-use peptide.
Track Your CJC-1295 Protocol — Free
Whether you are on the DAC or No DAC form, Shotlee tracks every injection, dose, and timing detail so your protocol data is always with you.
Get Shotlee Free